India is a big market population wise but still isn’t coming to the party for such treatments- people are missing out on diagnosis/ treatments as insurance companies may not support such pricey treatments and it is out of reach for the common people to pay out of pocket.
Ann: Dimerix and Taiba enter into License Agreement for DMX-200, page-57
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $214.5M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 39.3¢ | 38.5¢ | $275.1K | 709.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49999 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 200000 | 2 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| DXB (ASX) Chart |